| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |